26 Apr 2017 | Livemint.com

BSE
NSE
Last Updated: Mar 31, 03:52 PM
Ceat Ltd.

BSE

  • 1,324.15 11.05 (0.84%)
  • Vol: 45140
  • BSE Code: 500878
  • PREV. CLOSE
    1,313.10
  • OPEN PRICE
    1,314.50
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    1,324.15(31)

NSE

  • 1,324.85 0.00 (0%)
  • Vol: 547431
  • NSE Code: CEATLTD
  • PREV. CLOSE
    1,324.85
  • OPEN PRICE
    1,319.90
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    1,324.85(92)

Ceat Ltd. Board Meetings

From date
To date
Source Date Board Meeting Date Details
21-Apr-201728-Apr-2017 Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, April 28, 2017, inter-alia, to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2017 and to recommend dividend, if any for the year ended March 31, 2017. The Company will also hold Q4 FY17 Earnings Conference Call on Friday, April 28, 2017 from 4.30 p.m. IST. Kindly take on record the above information and acknowledge receipt thereof. & Dividend & Audited Results
01-Feb-201707-Feb-2017 Quarterly Results
27-Oct-201607-Nov-2016 Quarterly Results
25-Jul-201628-Jul-2016 Quarterly Results & Ceat Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on Thursday, July 28, 2016, inter alia, to consider and approve the Un-audited Financial Results for the quarter ended June 30, 2016 (Q1) and change in Key Managerial Personnel (KMP).
20-Apr-201627-Apr-2016 Audited Results
08-Mar-201616-Mar-2016 Interim Dividend
04-Feb-201612-Feb-2016 Quarterly Results
15-Oct-201527-Oct-2015 Quarterly Results
10-Jul-201522-Jul-2015 Quarterly Results
11-May-201522-May-2015 Audited Results & Dividend
23-Jan-201505-Feb-2015 Quarterly Results
20-Oct-201430-Oct-2014 Quarterly Results
22-Aug-201426-Aug-2014 The Board of Directors of the Company will be held on August 26, 2014, inter alia, for considering further issue of securities through issuance of equity shares or debentures or equity linked securities and/or any instrument convertible into equity shares by way of private or public offerings, including qualified institutes placement and/or on a preferential allotment basis.